Related Experiment Video

Updated: Jun 11, 2026

Co-immunoprecipitation of the Mouse Mx1 Protein with the Influenza A Virus Nucleoprotein
09:39

Co-immunoprecipitation of the Mouse Mx1 Protein with the Influenza A Virus Nucleoprotein

Published on: April 21, 2015

Genetic control of immune responses to influenza A matrix 2 protein (M2)

Julia A Misplon1, Chia-Yun Lo, Jon D Gabbard

  • 1Food and Drug Administration, Center for Biologics and Research, HFM-730, Rockville, MD 20852, USA.

Vaccine
|July 6, 2010
PubMed

Insights

Influenza A matrix protein 2 (M2) vaccine responses vary significantly across genetically diverse mouse strains. Co-immunization with nucleoprotein (NP) improved vaccine efficacy, suggesting strategies for broader population protection.

Area of Science:

  • Immunology
  • Vaccinology
  • Genetics

Background:

  • The development of universal vaccines necessitates efficacy across genetically diverse populations.
  • Influenza A matrix protein 2 (M2) is a target for a potential "universal" influenza vaccine.
  • Genetic background significantly influences immune responses to vaccination.

Purpose of the Study:

  • To evaluate the immunogenicity and efficacy of a candidate universal influenza A M2 vaccine in diverse mouse strains.
  • To investigate the impact of host genetic diversity on M2 vaccine responses.
  • To explore strategies for enhancing M2 vaccine responses in low-responder genetic backgrounds.

Main Methods:

  • Mice from different genetic backgrounds (C57BL/6, BALB/c, CBA) were immunized with M2 DNA prime and M2 recombinant adenovirus (rAd) boost.
  • Immune responses were assessed by measuring antibody and T-cell reactivity to M2.
  • Alternative immunization strategies, including adjuvanted peptide-carrier conjugates and co-immunization with influenza nucleoprotein (NP), were tested to enhance responses.

Main Results:

  • Significant genetic variation in M2-specific immune responses was observed; C57BL/6 mice showed minimal response, BALB/c responded strongly, and CBA showed intermediate responses.
  • Both MHC and non-MHC background genes were identified as key factors influencing M2 vaccine responsiveness.
  • Co-immunization with NP significantly improved vaccine outcomes compared to M2 or NP immunization alone, while conjugate vaccines showed variable effects.

Conclusions:

  • Host genetic diversity profoundly impacts the efficacy of the candidate universal influenza A M2 vaccine.
  • Co-administration with influenza nucleoprotein (NP) represents a promising strategy to augment T-cell help and improve vaccine effectiveness in diverse populations.
  • These findings highlight the importance of considering genetic factors in the design of broadly protective influenza vaccines.

More Related Videos

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity10:39

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity

Published on: June 25, 2015

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies07:55

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies

Published on: August 29, 2017

Related Concept Videos

Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...